American society

The prospect of a well-paying job at 18 or 19

Robert W. Foster President Biden wants to spend $ 2.3 trillion on improving America’s infrastructure in response to realities that the American Society of Civil Engineers gave our national infrastructure a C-minus rating in its 2021 report. a local example, ASCE reports that 9% of Massachusetts bridges are structurally deficient.) …

Read More »

Advice on contraception, gene therapy, gout treatment

Disease-modifying anti-rheumatic drugs (DMARDs) used in RA may have potential teratogenic effects on the fetus. In an observational study, researchers looked at 2 years of medical records from a rheumatology clinic in Colorado, the primary endpoint being the prevalence and type of contraceptive use in patients aged 18 to 44. …

Read More »

Lucinda McDade of Claremont University Graduate honored by the American Horticultural Society – Daily Bulletin

Lucinda McDade, Executive Director and Judith B. Friend Director of Research at the California Botanic Garden, was named the 2021 recipient of the American Horticultural Society’s Liberty Hyde Bailey Award, the organization’s highest honor. The award is presented to an individual who has made a significant contribution during their lifetime …

Read More »

Intensity Therapeutics Announces Presentation of Two Abstracts at American Society of Clinical Oncology (ASCO) Annual Meeting 2021

Intensity Therapeutics, Inc. (“Intensity”), a clinical-stage biotechnology company developing proprietary intratumoral products to kill tumors and increase recognition of cancers by the immune system, today announced two poster presentations at the occasion of the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting to be held virtually June 4-8. Title: …

Read More »

Oncopeptides Announces Three Abstracts Accepted By American Society of Clinical Oncology 2021

WALTHAM, Massachusetts, May 19, 2021 / PRNewswire / – Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotechnology company focused on developing therapies for difficult-to-treat hematologic diseases, today announces that three abstracts containing data on PEPAXTO® (melphalan flufenamide, also known as melflufen) in relapsed refractory multiple myeloma, have been accepted …

Read More »